Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 1, 1988
Local tolerance and activity of MK-927, a novel topical carbonic anhydrase inhibitorE A Lippa, H A von Denffer, H M Hofmann, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 1, 1991
Comparative tolerability of topical carbonic anhydrase inhibitor MK-927 and its S-enantiomer MK-417N Pfeiffer, J Gerling, E A Lippa, et al.The British Journal of Ophthalmology|July 1, 1990
A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patientsN Pfeiffer, R Hennekes, E A Lippa, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|January 1, 1990
.008% timolol ophthalmic solution. A minimal-effect dose in a normal volunteer modelL S Mottow-Lippa, E A Lippa, M A Naidoff, et al.Clinical Pharmacology and Therapeutics|June 1, 1991
Assessment of systemic effects of different ophthalmic beta-blockers in healthy volunteersK Bauer, F Brunner-Ferber, L M Distlerath, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|June 1, 1990
MK-927, a topical carbonic anhydrase inhibitor. Dose response and reproducibilityJ B Serle, J S Lustgarten, E A Lippa, et al.Fortschritte Der Ophthalmologie : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 1, 1991
[Additive effect of timolol and the local carbonic anhydrase inhibitor MK-417 (sezolamide)]N Pfeiffer, E Greve, A Béchetoille, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|January 1, 1990
MK-927: a topical carbonic anhydrase inhibitor. Dose response and duration of actionE J Higginbotham, M A Kass, E A Lippa, et al.British Journal of Clinical Pharmacology|August 1, 1992
Assessment of bronchial effects following topical administration of butylamino-phenoxy-propanol-acetate, an oculoselective beta-adrenoceptor blocker in asthmatic subjectsK G Bauer, F Brunner-Ferber, L M Distlerath, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|October 1, 1993
Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitorM Wilkerson, M Cyrlin, E A Lippa, et al.Pageof 2